Precision Biotics Market
Precision Biotics Market by Type (Precision Probiotics, Next-generation Probiotics, Synbiotics, Postbiotics), End-use Industry, Health/Functional Positioning, Distribution Channel, and Region - Global Forecast to 2031
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The precision biotics market is projected to reach USD 9.26 billion by 2031 from USD 4.91 billion in 2026, at a CAGR of 13.5% from 2026 to 2031. The growth of this market is driven by the increasing adoption of personalized nutrition, expanding microbiome research, rising prevalence of gastrointestinal and metabolic disorders, growing consumer awareness of preventive healthcare, and advancements in microbiome sequencing, AI, and multi-omics technologies supporting precision biotics development worldwide.
Market Size and Forecast:
- Market Size Value in 2025: USD 4.33 Billion
- Market Size Value in 2026: USD 4.91 Billion
- Revenue Forecast in 2031: USD 9.26 Billion
- Growth Rate: CAGR of 13.5% from 2026 to 2031
- Forecast period: 2026–2031
- North America is estimated to account for the largest share of about 37.6% of the precision biotics market in 2026.
- The precision probiotics segment is estimated to dominate the market with a share of 53.8% in 2026.
Key Market Trends and Insights
- By Type: The Precision Probiotics segment accounts for a significant share of the precision biotics market, driven by increasing demand for scientifically validated, targeted microbiome solutions that support digestive, immune, metabolic, and cognitive health.
- Market Trends: Consumers are increasingly adopting personalized nutrition, microbiome-based wellness, preventive healthcare, and clinically validated biotic products. Advances in microbiome sequencing, multi-omics technologies, and artificial intelligence are accelerating the development of more precise and personalized precision biotics.
- Market Drivers: Rising awareness of the gut microbiome’s role in overall health, increasing prevalence of lifestyle-related diseases, expanding investments in microbiome research, growing collaborations between biotechnology and nutrition companies, and increasing demand for functional foods, dietary supplements, and medical nutrition are driving market growth.
- Future Opportunities: Significant opportunities are emerging from the rapid adoption of next-generation probiotics (NGPs), expanding applications in skin microbiome-friendly cosmetics, increasing demand for personalized healthcare, growing penetration in emerging Asia Pacific markets, and continued innovation in AI-driven microbiome research and clinically validated precision nutrition solutions.
KEY TAKEAWAYS
-
BY REGIONNorth America is estimated to account for the largest share of about 37.6% of the precision biotics market in 2026.
-
BY TYPEBy type, the precision probiotics segment is estimated to dominate the market with a share of 53.8% in 2026.
-
BY END-USE INDUSTRYBy end-use industry, the cosmetics segment is projected to witness a high CAGR of 18.8% from 2026 to 2031.
-
BY HEALTH/FUNCTIONAL POSITIONINGBy health/functional positioning, type A gelatin is expected to hold a dominant market share.
-
COMPETITIVE LANDSCAPE - KEY PLAYERSNovonesis Group (Denmark), Procter & Gamble (US), and Unilever (UK) were identified as some of the star players in the precision biotics market (global), given their global presence and strong product footprint.
-
COMPETITIVE LANDSCAPE - STARTUPS/SMEsPendulum (US) and Seed Health, Inc (US) have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The precision biotics market is experiencing substantial growth. This is primarily driven by the increasing adoption of personalized nutrition, growing consumer awareness of gut health and preventive healthcare, expanding microbiome research, and rising demand for clinically validated, strain-specific probiotic solutions across the dietary supplements, functional food & beverages, pharmaceutical, and infant nutrition industries.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
Customer business in the precision biotics market is driven by the growing demand for personalized nutrition, microbiome-based healthcare, and preventive wellness. Demand is shifting toward personalized gut health products, next-generation probiotics, synbiotics, women's health probiotics, and AI-enabled microbiome solutions, driving innovation and revenue growth for precision biotics manufacturers, personalized nutrition companies, online wellness platforms, and health & wellness retailers.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Growing Adoption of Personalized & Targeted Nutrition and Microbiome-based Healthcare
-
Growing Incidence of Gastrointestinal Disorders
Level
-
High Development Costs of Strain-specific Precision Biotics
-
Complex Regulatory Pathways for Personalized Microbiome Products
Level
-
Increasing Partnerships Between Biotech Firms and Healthcare Providers
-
Rising Demand for Precision Nutrition in Chronic Disease Management
Level
-
Ensuring Strain Stability and Product Quality Across Supply Chains
-
Need for Robust Clinical Evidence to Support Health Claims
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Growing Adoption of Personalized & Targeted Nutrition and Microbiome-based Healthcare
Rising consumer demand for personalized nutrition and microbiome-based healthcare is increasing the adoption of strain-specific precision biotics, driving product innovation and market growth.
Restraint: High Development Costs of Strain-specific Precision Biotics
High costs associated with microbiome research, clinical validation, and personalized product development increase commercialization expenses, limiting market penetration and affordability.
Opportunity: Increasing Partnerships Between Biotech Firms and Healthcare Providers
Collaborations between biotech companies, healthcare providers, and digital health platforms are accelerating precision biotics development, expanding clinical adoption, and improving consumer access.
Challenge: Ensuring Strain Stability and Product Quality Across Supply Chains
Maintaining probiotic strain viability, stability, and consistent product quality throughout manufacturing, storage, and distribution remains a key challenge affecting consumer confidence and regulatory compliance.
PRECISION BIOTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Pendulum developed Pendulum Glucose Control, a precision probiotic formulated with proprietary next-generation bacterial strains to increase butyrate production, support GLP-1 secretion, and improve blood glucose metabolism using an acid-resistant delivery capsule. | Supports healthy blood glucose levels, improves gut barrier function, enhances butyrate production, and ensures effective delivery of live probiotic strains. |
 |
Seed developed DS-01 Daily Synbiotic, a strain-specific synbiotic formulated using microbiome science and advanced capsule technology to support digestive, immune, skin, and cardiovascular health. | Enhances probiotic survival, supports multiple health outcomes, and provides clinically researched strain-specific benefits |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The precision biotics market ecosystem is categorized into precision biotics manufacturers, regulatory bodies, startups/SMEs, and distributors. The precision biotics market is a dynamic and rapidly evolving ecosystem characterized by microbiome technology providers, personalized nutrition companies, healthcare professionals, digital health platforms, and expanding applications across digestive, metabolic, immune, women's health, skin, pediatric, oral, and gut-brain health. Established companies and agile startups are central to this market, and they develop innovative precision biotics products.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Precision Biotics Market, By Type
Precision probiotics dominate the market under type, owing to their clinically validated, strain-specific formulations that deliver targeted health benefits and support the growing demand for personalized microbiome-based healthcare.
Precision Biotics Market, By Health & Functional Position
Digestive & gastrointestinal health accounts for the largest share in the health/ functional positioning segment of the precision biotics market due to the high prevalence of gut disorders, increasing consumer awareness of gut health, and strong demand for clinically validated digestive health solutions.
Precision Biotics Market, By End-use Industry
Dietary supplements under end-use industry dominate the precision biotics market, driven by rising adoption of preventive healthcare, personalized nutrition, and growing consumer preference for convenient microbiome-based supplements.
REGION
Asia Pacific is the fastest-growing region in the precision biotics market
Asia Pacific is projected to be the fastest-growing region in the global precision biotics market. The region's rapid growth is driven by increasing adoption of personalized nutrition, rising consumer awareness of gut health and preventive healthcare, expanding microbiome research, growing demand for clinically validated probiotic supplements, and the rapid expansion of the dietary supplements and functional food industries, supported by improving healthcare infrastructure and e-commerce penetration.
PRECISION BIOTICS MARKET: COMPANY EVALUATION MATRIX
In the precision biotics market matrix, Novonesis Group (Denmark), Procter & Gamble (US), and Unilever (UK) (Star) lead with a moderate market share and extensive product portfolios, driven by their strong global presence, strong global footprint, advanced processing capabilities, diversified application offerings, and continuous investments in innovation. Probi (Sweden) - Symrise AG (Emerging Leader) is gaining visibility through specialized and cost-efficient precision biotic solutions, strengthening its market position through innovation and expanding regional reach.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- BioGaia (Sweden)
- Novonesis Group (Denmark)
- Procter & Gamble (P&G) (US)
- Unilever (UK)
- dsm-firmenich (Switzerland)
- Metagenics, LLC (US)
- Yakult Honsha Co., Ltd. (Japan)
- Danone (France)
- KANEKA CORPORATION (Japan)
- Symrise (Germany) - (Probi)
- Jarrow Formulas, Inc. (US)
- Pendulum Therapeutics (US)
- thegoodbug (India)
- Seed Health, Inc. (US)
- Infinant Health, Inc. (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2026 (Value) | USD 4.91 BN |
| Market Forecast in 2031 (Value) | USD 9.26 BN |
| Growth Rate | CAGR of 13.5% from 2026 to 2031 |
| Years Considered | 2022–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Billion), Volume (Tons) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Rest of the World |
WHAT IS IN IT FOR YOU: PRECISION BIOTICS MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Europe-based precision biotics manufacturers |
|
|
| Precision biotics segment assessment |
|
|
RECENT DEVELOPMENTS
- January 2026 : Metagenics acquired UK-based probiotic brand Symprove, expanding its microbiome and gut health portfolio. The acquisition strengthens Metagenics' practitioner-recommended probiotic offerings by adding Symprove's clinically validated water-based probiotic technology, while a strategic debt recapitalization will support future growth and acquisitions.
- June 2025 : Danone acquired The Akkermansia Company (TAC), a Belgian biotechnology company specializing in next-generation biotics. The acquisition adds the clinically validated Akkermansia muciniphila MucT strain to Danone's portfolio, strengthening its capabilities in gut health, metabolic health, and precision nutrition as part of its Renew strategy.
- December 2024 : BioGaia launched BioGaia Gastrus PURE ACTION, a double-strength probiotic containing L. reuteri DSM 17938 and ATCC PTA 6475, designed to support digestive health and relieve IBS symptoms in individuals with sensitive digestive systems.
- December 2024 : GluCare.Health collaborated with Pendulum Therapeutics to evaluate the impact of Pendulum's next-generation precision probiotics on metabolic health in individuals with prediabetes and type 2 diabetes through GluCare's AI-enabled care platform.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This study employed two primary approaches to estimate the current size of the precision biotics market. Exhaustive secondary research was carried out to collect information on the precision biotics type, end-user industry, health/functional positioning, distribution channel, and region. The next step involved validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, data triangulation was used to estimate the market size of segments and subsegments.
Secondary Research
This research study used extensive secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information for a technical, market-oriented, and commercial market study. In the secondary research process, sources such as annual reports, press releases & investor presentations of companies, white papers, agriculture and precision biotics-related journals, certified publications, articles from recognized authors, directories, and databases were referred to identify and collect information. Secondary research was mainly used to obtain key information about the industry’s supply chain, the pool of key players, and market classification and segmentation based on industry trends to the bottom-most level, regional markets, and key developments from market- and technology-oriented perspectives.
Primary Research
Extensive primary research was conducted after obtaining information regarding the precision biotics market scenario through secondary research. Several primary interviews were conducted with market experts from the demand and supply sides. Primary data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as chief experience officers (CXOs), vice presidents (VPs), directors from business development, marketing, research, and development teams, and related key executives from distributors and key opinion leaders.
Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped to understand the various trends related to precision biotics type, end-use industry, health/functional positioning, distribution channel, and region. Stakeholders from the demand side, including consumers, healthcare professionals, gastroenterologists, dietitians, nutritionists, functional medicine practitioners, hospitals and specialty clinics, pharmacies, e-commerce retailers, health & wellness retailers, and personalized nutrition platforms, were interviewed to understand buyers' perspectives on product efficacy, brand preferences, purchasing behavior, distribution channels, pricing trends, and the future outlook of the precision biotics market.
Breakdown of Primary Interviews
Note: The three tiers of the companies are defined based on their total revenues in 2023 or 2024, based on the availability of financial data: Tier 1: Revenue >USD 1 billion; Tier 2: USD 100 million ≤ revenue ≤ USD 1 billion; Tier 3: Revenue <USD 100 million.
|
COMPANY |
DESIGNATION |
|
BioGaia (Sweden) |
Regional Sales Manager |
|
Pendulum (US) |
Marketing Manager |
|
Seed Health, Inc (US) |
General Manager |
|
Infinant Health Inc (US) |
Sales Manager |
|
thegoodbug (India) |
Sales Manager |
|
Symrise (Germany)- (Probi) |
Sales Executive |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The top-down and bottom-up approaches were used to estimate and validate the total size of the precision biotics market. These approaches were also used extensively to determine the size of various subsegments in the market. The research methodology used to estimate the market size includes the following details:
- The key players in the industry and the overall markets were identified through extensive secondary research.
- All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
- All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.
- The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.
Precision Biotics Market: Top-Down and Bottom-Up Approach
Data Triangulation
After determining the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to estimate the overall precision biotics market and obtain precise statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using the top-down and bottom-up approaches.
Market Definition
The precision biotics market encompasses the development, manufacturing, distribution, and commercialization of targeted microbiome-based products designed to deliver specific health benefits using scientifically validated probiotic strains and personalized formulations. Leveraging microbiome science, AI, genomics, and multi-omics technologies, these products support applications such as digestive, metabolic, immune, gut-brain, skin, women's, pediatric, and oral health.
The market is driven by the growing demand for personalized nutrition, increasing prevalence of chronic diseases, expanding microbiome research, and advancements in precision health technologies. Rising consumer awareness of preventive healthcare and the availability of clinically validated strain-specific probiotic products continue to support the global growth of the precision biotics market.
Key Stakeholders
- Supply-side: Precision biotics manufacturers, probiotic strain developers, microbiome sequencing companies, ingredient suppliers, contract development and manufacturing organizations (CDMOs), packaging providers, distributors, and logistics partners
- Demand-side: Consumers, pharmacies, e-commerce retailers, health & wellness stores, hospitals, specialty clinics, gastroenterologists, dietitians, nutritionists, functional medicine practitioners, and personalized nutrition platforms adopting precision biotics for targeted health management
- Regulatory side: Food safety authorities, pharmaceutical regulatory agencies, dietary supplement regulatory bodies, quality assurance organizations, and standards agencies overseeing probiotic safety, health claims, clinical evidence, labeling, and manufacturing compliance
-
Associations and industry bodies:
- European Food Safety Authority (EFSA)
- World Health Organization (WHO)
- US Food and Drug Administration (USFDA)
- Food Safety and Standards Authority of India (FSSAI)
- Food and Agriculture Organization (FAO)
- International Scientific Association for Probiotics and Prebiotics (ISAPP)
- International Probiotics Association (IPA)
- Consumer Healthcare Products Association (CHPA)
Report Objectives
- To determine and project the size of the precision biotics market based on type, end-use industry, health/functional positioning, distribution channel, and region over the forecast period
- To identify key growth opportunities by analyzing the largest and fastest-growing segments across regions
- To provide detailed insights on factors influencing market growth, including drivers, restraints, opportunities, and challenges
- To evaluate market opportunities for stakeholders and present the competitive landscape of leading players
- To analyze micro-markets with respect to individual growth trends, future potential, and their contribution to the overall market
- To identify and profile key companies operating in the precision biotics market
- To assess the competitive environment and highlight key strategies adopted by major players across regions
Available customizations:
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs. The following customization options are available for the report:
Product Analysis
-
Product matrix, which gives a detailed comparison of the product portfolio of each company.
Segmental Analysis
-
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
- Further breakdown of the Rest of Europe precision biotics market into key countries
- Further breakdown of the Rest of Asia Pacific precision biotics market into key countries
Company Information
- Detailed analyses and profiling of additional market players (up to five)
Key Questions Addressed by the Report
What is the projected growth of the precision biotics market?
According to MarketsandMarkets, the global precision biotics market is projected to grow from USD 4.91 billion in 2026 to USD 9.26 billion by 2031, at a CAGR of 13.5% during the forecast period.
What are the key factors driving the precision biotics market?
The market is driven by increasing awareness of gut microbiome health, growing demand for personalized nutrition, advancements in microbiome science, rising prevalence of chronic lifestyle diseases, and increasing investments in microbiome sequencing, artificial intelligence, and clinical research.
Which region is expected to witness the fastest growth in the precision biotics market?
Asia Pacific is expected to register the fastest growth due to increasing consumer awareness of gut health, expanding dietary supplements and functional foods industries, rising disposable incomes, and growing adoption of personalized healthcare solutions.
Which product segment is expected to grow the fastest?
The next-generation probiotics (NGPs) segment is expected to grow at the highest rate during the forecast period, supported by advancements in microbiome research, strain-specific health benefits, and expanding applications in digestive, metabolic, immune, and women's health.
Who are the major players in the precision biotics market?
Key companies operating in the market include BioGaia (Sweden), Novonesis Group (Denmark), Procter & Gamble (US), Unilever (UK), dsm-firmenich (Switzerland), Metagenics, LLC (US), Yakult Honsha Co., Ltd. (Japan), Danone (France), KANEKA CORPORATION (Japan), Symrise (Germany), Jarrow Formulas, Inc. (US), Pendulum (US), thegoodbug (India), Seed Health, Inc. (US), and Infinant Health Inc. (US).
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Precision Biotics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Growth opportunities and latent adjacency in Precision Biotics Market